Malouf syndrome

From WikiMD's WELLNESSPEDIA


Malouf syndrome
Synonyms Congenital heart defects, dysmorphic facial features, and intellectual disability
Pronounce N/A
Specialty Medical genetics
Symptoms Congenital heart defects, dysmorphic facial features, intellectual disability
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Noonan syndrome, Williams syndrome
Prevention N/A
Treatment Symptomatic treatment, supportive care
Medication N/A
Prognosis N/A
Frequency Rare disease
Deaths N/A


Malouf Syndrome is a rare genetic disorder characterized by a combination of symptoms including heart disease, endocrine dysfunction, and developmental delays. The syndrome was first described by Dr. Nabil Malouf in 1988.

Symptoms and Signs[edit]

The symptoms of Malouf Syndrome can vary greatly from person to person. However, some common symptoms include:

  • Heart disease: This is often the most serious symptom of Malouf Syndrome. It can lead to heart failure and other complications.
  • Endocrine dysfunction: This can cause a variety of symptoms, including growth delays, sexual development issues, and metabolic problems.
  • Developmental delays: Many people with Malouf Syndrome have intellectual disabilities or developmental delays.

Causes[edit]

Malouf Syndrome is caused by mutations in the genes that regulate the development and function of the heart and endocrine system. The exact genes involved are not yet known.

Diagnosis[edit]

Diagnosis of Malouf Syndrome is based on the presence of the characteristic symptoms and signs. Genetic testing can confirm the diagnosis.

Treatment[edit]

Treatment for Malouf Syndrome is focused on managing the symptoms. This can include medications to treat heart disease, hormone therapy for endocrine dysfunction, and special education for developmental delays.

Prognosis[edit]

The prognosis for people with Malouf Syndrome varies depending on the severity of the symptoms. With appropriate treatment, many people with Malouf Syndrome can live healthy, productive lives.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.